Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Behnes

Showing results (171-180 of 331) with videos related to

Pageof 34
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 15, 2024
Prognostic impact of prior LVEF in patients with heart failure with mildly reduced ejection fractionAlexander Schmitt, Michael Behnes, Kathrin Weidner, et al.
Journal of Clinical Medicine|January 23, 2024
Prognostic Implications of Septal Hypertrophy in Patients with Heart Failure with Mildly Reduced Ejection FractionNoah Abel, Tobias Schupp, Mohammad Abumayyaleh, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|March 31, 2024
Prognostic value of mitral valve regurgitation in patients with heart failure with mildly reduced ejection fractionNoah Abel, Michael Behnes, Alexander Schmitt, et al.
Journal of Clinical Medicine|October 26, 2024
Prognostic Impact of Anemia and Hemoglobin Levels in Unselected Patients Undergoing Coronary AngiographyPhilipp Steinke, Tobias Schupp, Lasse Kuhn, et al.
International Journal of Cardiology|January 31, 2016
Response to letter: Device therapy and aldosterone antagonists in the prognosis of heart failureMichael Behnes, Thomas Bertsch, Christel Weiss, et al.
International Journal of Cardiology|November 6, 2015
Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patientsMichael Behnes, Thomas Bertsch, Christel Weiss, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 19, 2026
Prevalence and prognosis of multimorbidity in heart failure with mildly reduced ejection fractionMarielen Reinhardt, Michael Behnes, Mohammad Abumayyaleh, et al.
European Journal of Clinical Investigation|December 26, 2025
Albumin, urea-to-albumin ratio, or the albumin-to-creatinine ratio to predict outcomes in heart failure with mildly reduced ejection fractionAlexander Schmitt, Ibrahim Akin, Marielen Reinhardt, et al.
European Journal of Preventive Cardiology|March 21, 2024
Effect of heart failure pharmacotherapies in patients with heart failure with mildly reduced ejection fractionTobias Schupp, Thomas Bertsch, Marielen Reinhardt, et al.
Journal of Clinical Medicine|May 11, 2024
Characteristics Associated with Ventricular Tachyarrhythmias and Their Prognostic Impact in Heart Failure with Mildly Reduced Ejection FractionAlexander Schmitt, Michael Behnes, Jonas Rusnak, et al.
Pageof 34

Showing results (171-180 of 331) with videos related to

Sort By:
Pageof 34
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 15, 2024
Prognostic impact of prior LVEF in patients with heart failure with mildly reduced ejection fractionAlexander Schmitt, Michael Behnes, Kathrin Weidner, et al.
Journal of Clinical Medicine|January 23, 2024
Prognostic Implications of Septal Hypertrophy in Patients with Heart Failure with Mildly Reduced Ejection FractionNoah Abel, Tobias Schupp, Mohammad Abumayyaleh, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|March 31, 2024
Prognostic value of mitral valve regurgitation in patients with heart failure with mildly reduced ejection fractionNoah Abel, Michael Behnes, Alexander Schmitt, et al.
Journal of Clinical Medicine|October 26, 2024
Prognostic Impact of Anemia and Hemoglobin Levels in Unselected Patients Undergoing Coronary AngiographyPhilipp Steinke, Tobias Schupp, Lasse Kuhn, et al.
International Journal of Cardiology|January 31, 2016
Response to letter: Device therapy and aldosterone antagonists in the prognosis of heart failureMichael Behnes, Thomas Bertsch, Christel Weiss, et al.
International Journal of Cardiology|November 6, 2015
Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patientsMichael Behnes, Thomas Bertsch, Christel Weiss, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 19, 2026
Prevalence and prognosis of multimorbidity in heart failure with mildly reduced ejection fractionMarielen Reinhardt, Michael Behnes, Mohammad Abumayyaleh, et al.
European Journal of Clinical Investigation|December 26, 2025
Albumin, urea-to-albumin ratio, or the albumin-to-creatinine ratio to predict outcomes in heart failure with mildly reduced ejection fractionAlexander Schmitt, Ibrahim Akin, Marielen Reinhardt, et al.
European Journal of Preventive Cardiology|March 21, 2024
Effect of heart failure pharmacotherapies in patients with heart failure with mildly reduced ejection fractionTobias Schupp, Thomas Bertsch, Marielen Reinhardt, et al.
Journal of Clinical Medicine|May 11, 2024
Characteristics Associated with Ventricular Tachyarrhythmias and Their Prognostic Impact in Heart Failure with Mildly Reduced Ejection FractionAlexander Schmitt, Michael Behnes, Jonas Rusnak, et al.
Pageof 34